YOLO
Lv53
1230 积分
2021-08-23 加入
-
Low-frequency magnetic field therapy for glioblastoma: Current advances, mechanisms, challenges and future perspectives
12天前
已完结
-
A prospective, longitudinal study of platelet serotonin and plasma brain-derived neurotrophic factor concentrations in major depression: effects of vortioxetine treatment
1个月前
已完结
-
A review of the clinical efficacy, safety and tolerability of the antidepressants vilazodone, levomilnacipran and vortioxetine
1个月前
已完结
-
Distinct association of plasma BDNF concentration and cognitive function in depressed patients treated with vortioxetine or escitalopram
1个月前
已完结
-
Integrative Spatial Analysis Reveals Tumor Heterogeneity and Immune Colony Niche Related to Clinical-Outcomes in Small Cell Lung Cancer
2个月前
已关闭
-
BDNF/TrkB signaling protects HT-29 human colon cancer cells from EGFR inhibition
2个月前
已完结
-
Trans-ancestry genome-wide study of depression identifies 697 associations implicating cell types and pharmacotherapies
3个月前
已完结
-
206. Identification and Prospective Replication of a Cognitive Biomarker for Predicting the Antidepressant Effect of ALTO-100, a Novel Pro-Plasticity Drug Candidate, in Patients With Major Depression: Results From a Large Phase 2a Study
3个月前
已完结
-
Development and Prospective Replication of Biomarkers for Predicting Treatment Outcome With ALTO-100 and ALTO-300 in Major Depression: Data From Multiple Phase 2 Programs
3个月前
已完结
-
Safety and efficacy of intravenous recombinant human prourokinase for acute ischaemic stroke within 4·5 h after stroke onset (PROST-2): a phase 3, open-label, non-inferiority, randomised controlled trial
4个月前
已完结